Direktorat Registrasi ObatValid

RENAPAR

Claim this product
BPOM Number
DKL9131503409A1
Approved
23 June 2026
Expiry
23 June 2031
Form
KAPLET SALUT SELAPUT

About This Registration

RENAPAR is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL9131503409A1. Its current registration status is Valid, with the licence valid until 23 June 2031. The product is registered to PRATAPA NIRMALA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 30 June 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 10 STRIP @ 10 KAPLET SALUT SELAPUT
Department
Direktorat Registrasi Obat
Data Last Updated
30 June 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (4)

MAGNESIUM ASPARTATE DIHYDRATE<POTASSIUM HYDROGEN ASPARTATE HEMIHYDRATE. MAGNESIUM ASPARTATE DIHYDRATEBR>POTASSIUM HYDROGEN ASPARTATE HEMIHYDRATE

Market Intelligence

Owner Portfolio
PRATAPA NIRMALA - INDONESIA holds 454 BPOM registrations
Manufacturer Scale
PRATAPA NIRMALA - INDONESIA produces 454 registered products
Registration Age
Registered for 3 months

FDA Cross-Reference

via openFDA
Generic Name
PAREIRA BRAVA, PETROSELINUM SATIVUM, SARSAPARILLA (SMILAX REGELII), KIDNEY (SUIS), BRYONIA (ALBA), MERCURIUS CORROSIVUS, RUBIA TINCTORUM, SOLIDAGO VIRGAUREA, TRITICUM REPENS
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
Purpose
INDICATIONS: May temporarily relieve sudden desire to urinate, urination difficult and scanty, and frequent urging on urination.** **Claims based on traditional homeopathic practice, not accepted medi

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1